Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
They are as follows: 503A: 503A compounding medications help provide a personalized experience by providing customized medications according to the patients requirements
The goal is care thats realistic, consistent, and built around your life
Meet the experts : Alexandra Sowa, MD, is an internal medicine doctor specializing in preventative health, nutrition, and obesity medicine and the author of the forthcoming book The Ozempic Revolution
SURMOUNT-1 results (72 weeks, adults with obesity): 5 mg dose: approximately 15% body weight loss 10 mg dose: 19.5% body weight loss 15 mg dose: 22.5% body weight loss Placebo: 3.1% body weight loss At the 15 mg maximum dose, the average participant lost about 52 pounds over 72 weeks
